Merck's Actions on Vioxx Face New Scrutiny

But Wall Street analysts and battalions of lawyers will be intently watching testimony by and about Merck because the company faces hundreds of lawsuits over Vioxx, some of them scheduled to go to trial as early as May in Alabama and Texas. Consolidated groups of cases are headed for trial in California and New Jersey this summer.

(NY TIMES)